Pharma enters ‘age of uncertainty’ amid challenges from IRA, FTC and patent cliffs
It’s been a demanding year for the pharma industry. There’s a more aggressive FTC, a changing FDA, tough market conditions, and a legal fight over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
